Cell biology startup Transition Bio hires first CEO

Nearly a year after its public launching, Transition Bio has its first CEO in Gregory Miller, who was the second employee at another local startup, neurodegenerative disease-focused Atalanta Therapeutics. Miller has been working with Transition for about the past five months as a strategic advisor. When he joined last month, it was the first time he had stepped into the corner office. Miller was chief business officer at Atalanta as well as Waltham-based Visterra Inc. before that. He also held…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news